These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 31926146

  • 1. Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus-like particle vaccine candidates.
    Guo J, Lu Y, Zhang Y, Mugabe S, Wei Z, Borisov OV.
    Anal Biochem; 2020 Mar 01; 592():113577. PubMed ID: 31926146
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD.
    Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C, Li C, Wang J, Hashem AM, Jaentschke B, Van Domselaar G, He R, Li X.
    J Vis Exp; 2011 Apr 04; (50):. PubMed ID: 21490585
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL, Pirkle JL, Barr JR.
    Vaccine; 2012 Mar 23; 30(14):2475-82. PubMed ID: 22197963
    [Abstract] [Full Text] [Related]

  • 5. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines.
    Getie-Kebtie M, Sultana I, Eichelberger M, Alterman M.
    Influenza Other Respir Viruses; 2013 Jul 23; 7(4):521-30. PubMed ID: 22943763
    [Abstract] [Full Text] [Related]

  • 6. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
    Schmeisser F, Jing X, Joshi M, Vasudevan A, Soto J, Li X, Choudhary A, Baichoo N, Resnick J, Ye Z, McCormick W, Weir JP.
    Influenza Other Respir Viruses; 2016 Mar 23; 10(2):134-40. PubMed ID: 26616263
    [Abstract] [Full Text] [Related]

  • 7. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A.
    Vaccine; 2016 Jun 17; 34(29):3371-80. PubMed ID: 27155499
    [Abstract] [Full Text] [Related]

  • 8. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J, Vandenberg K, Laurie K, Barr IG, Zhang Y, Rockman S.
    Front Immunol; 2023 Jun 17; 14():1147028. PubMed ID: 37033922
    [Abstract] [Full Text] [Related]

  • 9. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.
    J Virol Methods; 2011 Dec 17; 178(1-2):129-36. PubMed ID: 21907241
    [Abstract] [Full Text] [Related]

  • 10. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M.
    Vaccine; 2011 Apr 18; 29(18):3377-89. PubMed ID: 21397719
    [Abstract] [Full Text] [Related]

  • 11. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR, Byrne-Nash R, Gillis J, Bueter K, Couzens LK, Eichelberger MC, Rowlen KL.
    Vaccine; 2018 May 17; 36(21):2937-2945. PubMed ID: 29699789
    [Abstract] [Full Text] [Related]

  • 12. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.
    Pierce CL, Williams TL, Moura H, Pirkle JL, Cox NJ, Stevens J, Donis RO, Barr JR.
    Anal Chem; 2011 Jun 15; 83(12):4729-37. PubMed ID: 21591780
    [Abstract] [Full Text] [Related]

  • 13. Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
    Chae W, Kim P, Hwang BJ, Seong BL.
    Vaccine; 2019 Mar 07; 37(11):1457-1466. PubMed ID: 30765169
    [Abstract] [Full Text] [Related]

  • 14. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
    Johansson BE.
    Vaccine; 1999 Apr 09; 17(15-16):2073-80. PubMed ID: 10217609
    [Abstract] [Full Text] [Related]

  • 15. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
    Li X, Ju H, Liu J, Yang D, Qi X, Yang X, Qiu Y, Zheng J, Ge F, Zhou J.
    Influenza Other Respir Viruses; 2017 Nov 09; 11(6):518-524. PubMed ID: 28752641
    [Abstract] [Full Text] [Related]

  • 16. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
    Williams TL, Luna L, Guo Z, Cox NJ, Pirkle JL, Donis RO, Barr JR.
    Vaccine; 2008 May 12; 26(20):2510-20. PubMed ID: 18440105
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a recombinant influenza vaccine candidate using complementary LC-MS methods.
    Xie H, Doneanu C, Chen W, Rininger J, Mazzeo JR.
    Curr Pharm Biotechnol; 2011 Oct 12; 12(10):1568-79. PubMed ID: 21542793
    [Abstract] [Full Text] [Related]

  • 18. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y, Han L, Palladino G, Ferrari A, Xie Y, Carfi A, Dormitzer PR, Settembre EC.
    Vaccine; 2015 Oct 05; 33(41):5342-5349. PubMed ID: 26348403
    [Abstract] [Full Text] [Related]

  • 19. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM, Latham T, Cupo A.
    Viral Immunol; 2005 Oct 05; 18(2):365-72. PubMed ID: 16035948
    [Abstract] [Full Text] [Related]

  • 20. Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies.
    Narayan K, Paduraru C, Blake T, Arunachalam AB.
    Front Immunol; 2023 Oct 05; 14():1128683. PubMed ID: 37457687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.